Special Interest Group (SIG)

Academic Drug Discovery Special Interest Group (SIG)

Wednesday, February 7
12:00 PM - 1:15 PM
Location: 14B

The mission of the Academic Drug Discovery SIG is to enable greater interaction between academia, pharmaceutical research companies, suppliers and other technical companies. Through a range of unique programs and events, the Academic Drug Discovery SIG will build bridges between the academic and applied sciences. These ties will result in better skilled candidates for industry as well as enhanced support for academic centers with programs focused on drug discovery, screening, automation and related disciplines.

Marlene Jacobson

Associate Professor of Pharmacology
Moulder Center for Drug Discover Research, Temple University School Of Pharmacy

Dr. Jacobson received her bachelor degree in Chemistry from Douglass College, Rutgers University and her Ph.D. in Chemistry from the University of Delaware. Upon completion of her doctoral program, Dr. Jacobson was awarded a NIH Post-Doctoral Fellowship in Chemistry at MIT and secondary appointment as Visiting Fellow in Genetics at Harvard Medical School. In 1987, she joined Merck Research Labs where, over 24 years, she pursued drug discovery and preclinical development in areas of neuroscience, including schizophrenia, Alzheimer's disease and sleep disorders, pain and thrombosis. Dr. Jacobson is recognized for her contributions to the discovery and development of allosteric modulators of G-protein coupled receptors including muscarinic and metabotropic glutamate receptors. She has co-authored over 100 research publications, abstracts and patents. Dr. Jacobson's research interests include molecular pharmacology of allosteric modulators and biased ligands of G-protein coupled receptors, assay development and novel screening methodologies for drug discovery.

Presentation(s):

Send Email for Marlene Jacobson

Peter Gareiss

Biotechnology Associate
Yale Center for Molecular Discovery, Yale University

Pete Gareiss, Ph.D. has broad expertise in interdisciplinary biomedical research with primary expertise in biophysical chemistry, chemical biology, and high throughput screening as applied to the identification and characterization of compounds with therapeutic or biologic utility. His research has focused on the development and management of chemical libraries, the design and implementation of biochemical and cellular based assays for high throughput screening, and the biophysical characterization of biomolecular interactions. His graduate work was completed at the University of Rochester in 2008, after which he was a post-doctoral associate at Yale University. Pete joined the Yale Center for Molecular Discovery in 2010 and has focused on assay development, technology evaluation, and high throughput screening.

Presentation(s):

Send Email for Peter Gareiss

Catherine Tralau-Stewart

University of California San Francisco

Presentation(s):

Send Email for Catherine Tralau-Stewart


Assets

Academic Drug Discovery Special Interest Group (SIG)



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Academic Drug Discovery Special Interest Group (SIG)